Stay updated on Nivolumab Combinations in EGFR/ALK NSCLC Clinical Trial

Sign up to get notified when there's something new on the Nivolumab Combinations in EGFR/ALK NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab Combinations in EGFR/ALK NSCLC Clinical Trial page

  1. Check
    8 days ago
    Change Detected
    Summary
    Added related topics: Lung cancer and MedlinePlus Genetics.
    Difference
    0.1%
    Check dated 2026-04-13T01:46:31.000Z thumbnail image
  2. Check
    15 days ago
    No Change Detected
  3. Check
    22 days ago
    No Change Detected
  4. Check
    29 days ago
    Change Detected
    Summary
    Revision: v3.5.0 added; Lung cancer and related topics (MedlinePlus Genetics) removed; Revision: v3.4.3 removed.
    Difference
    0.2%
    Check dated 2026-03-22T11:25:07.000Z thumbnail image
  5. Check
    36 days ago
    Change Detected
    Summary
    Lung cancer and MedlinePlus Genetics were added as related topics on the study page.
    Difference
    0.1%
    Check dated 2026-03-15T04:38:20.000Z thumbnail image
  6. Check
    44 days ago
    Change Detected
    Summary
    Page revision updated from v3.4.2 to v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-08T02:45:13.000Z thumbnail image
  7. Check
    65 days ago
    Change Detected
    Summary
    Revision: v3.4.2 added. Lung cancer and related topics (MedlinePlus Genetics) and Revision: v3.4.1 were removed.
    Difference
    0.2%
    Check dated 2026-02-14T12:44:10.000Z thumbnail image
  8. Check
    72 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.4.1, replacing Revision: v3.4.0. This is a minor update to the revision metadata.
    Difference
    0.0%
    Check dated 2026-02-07T06:50:22.000Z thumbnail image

Stay in the know with updates to Nivolumab Combinations in EGFR/ALK NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab Combinations in EGFR/ALK NSCLC Clinical Trial page.